Lorazepam
NDC Package 63739-155-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lorazepam is a medication used to treat anxiety. Marketed by Mckesson Corporation, this product is identified by NDC 63739-155 and is authorized under FDA application ANDA071194.

Identification & Billing

NDC Package Code
63739-155-10
Package Description
10 BLISTER PACK in 1 BOX, UNIT-DOSE / 10 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
63739015510
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
10 EA

Clinical Specifications

Proprietary Name
Lorazepam
Dosage Form
-
Usage Information
This medication is used to treat anxiety. Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).

Regulatory & Marketing

Labeler Name
Mckesson Corporation
FDA Application #
ANDA071194
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-28-1999
End Marketing Date
09-01-2010
Listing Expiration
09-01-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63739-155-10 identifies a specific commercial package of 10 blister pack in 1 box, unit-dose / 10 tablet in 1 blister pack of Lorazepam, labeled by Mckesson Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson Corporation on July 28, 1999. The current certification is valid through September 01, 2010.

What are the primary indications for this medication?

This medication is used to treat anxiety. Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).

How is this Mckesson Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63739015510. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63739-155-10
11-Digit CMS (5-4-2)
63739-0155-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.